Supplier Product Identification Physical and Chemical Properties First Aid Measures Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity Hazards Identification
Home > 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione > 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione(51333-22-3)

16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione(51333-22-3)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity Hazards Identification
More
Less

Product Identification

Product Name

16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione

Synonyms

16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11b,16a)-

CAS

51333-22-3

Formula

C25H34O6

Molecular Weight

430.54

EINECS

257-139-7

RTECS

TU3723000

RTECS Class

Drug; Reproductive Effector; Human Data; Hormone

Merck

12,1490

Beilstein/Gmelin

3633996

Beilstein Reference

5-19-06-00575

More
Less

Physical and Chemical Properties

Solubility in water

Insoluble

Vapor Pressure

7E-17 (25 C)

pKa/pKb

12.85 (pKa)

Heat Of Vaporization

102.4 kJ/mol

Usage

An anti-inflammatory agent in the treatment of asthma, rhinitis, and inflammatory bowel disease.

More
Less

First Aid Measures

Ingestion

If swallowed, wash out mouth with water provided person is conscious. Call a physician.

Inhalation

If inhaled, remove to fresh air. If breathing becomes difficult, call a physician.

Skin

In case of skin contact, flush with copious amounts of water for at least 15 minutes. Remove contaminated clothing and shoes. Call a physician.

Eyes

In case of contact with eyes, flush with copious amounts of water for at least 15 minutes. Assure adequate flushing by separating the eyelids with fingers. Call a physician.

More
Less

Exposure Controls/Personal Protection

Personal Protection

Wear appropriate government approved respirator, chemical-resistant gloves, safety goggles, other protective clothing.

Exposure Effects

Harmful. Limited evidence of a carcinogenic effect. Possible teratogen.

More
Less

Fire Fighting Measures

Flash Point

202

Fire Fighting

Extinguish using Water spray. Carbon dioxide, dry chemical powder, or appropriate foam. Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.

More
Less

Accidental Release Measures

Small spills/leaks

Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Ventilate area and wash spill site after material pickup is complete.

More
Less

Stability and Reactivity

Stability

Stable at normal temperatures and pressures.

More
Less

Hazards Identification

EC Risk Phrase

40

EC Safety Phrase

22 36

More
Less

ContactMore

Bono Kangyuan (Beijing) Pharmaceutical Technology Co., Ltd
Tel
010-56380788-8515
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList827461/0.htm
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824
Fax
18140514863
WebSite
https://www.ruiweier.cn/
Hubei Hongfuda Biotechnology Co., Ltd.
WebSite
http://www.hfdpharm.com/
Hubei Chenxin Pharmaceutical Co., Ltd.
Fax
QQ:2544920688
WebSite
http://www.chenxinyaoye.cn
Shandong Yuhe Pharmaceutical Technology Co., LTD
Fax
QQ:2938966534
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList1136996/0.htm